Aptamer-engineered (nano)materials for theranostic applications
Theranostics · 2023
DOI: 10.7150/thno.85419 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, 2023. Verfasst von Navid Rabiee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Perth, WA 6150, Australia. Hauptthemen laut MEDLINE: Nanostructures, Aptamers, Nucleotide, Biosensing Techniques. Die Arbeit wurde bisher 55-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Perth, WA 6150, Australia.
- Perron Institute for Neurological and Translational Science, Perth, WA 6009, Australia.
- Student Research Committee, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Rabiee, N., Chen, S., Ahmadi, S., & Veedu, R. N. (2023). Aptamer-engineered (nano)materials for theranostic applications. Theranostics. https://doi.org/10.7150/thno.85419
Vancouver
Rabiee N, Chen S, Ahmadi S, Veedu RN. Aptamer-engineered (nano)materials for theranostic applications. Theranostics. 2023. doi:10.7150/thno.85419
BibTeX
@article{Rabiee2023,
author = {Rabiee, Navid and Chen, Suxiang and Ahmadi, Sepideh and Veedu, Rakesh N},
title = {Aptamer-engineered (nano)materials for theranostic applications},
journal = {Theranostics},
year = {2023},
doi = {10.7150/thno.85419}
}
EUVIMED